Ramvocid (oritavancin)
- Region
- 🇪🇺 EU
- Active substance
- oritavancin
- Company
- Targanta Netherlands B.V.
- Status
- Application withdrawn
- Therapeutic area
- Gram-Positive Bacterial Infections; Skin Diseases, Bacterial; Soft Tissue Infections
- Application
- EMEA/H/C/001025
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Tenkasi (previously Orbactiv) Authorised · Menarini International Operations Luxembourg S.A.
Follow Ramvocid
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.